全文获取类型
收费全文 | 872篇 |
免费 | 30篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 70篇 |
妇产科学 | 4篇 |
基础医学 | 78篇 |
口腔科学 | 21篇 |
临床医学 | 41篇 |
内科学 | 109篇 |
皮肤病学 | 36篇 |
神经病学 | 11篇 |
特种医学 | 51篇 |
外科学 | 82篇 |
综合类 | 279篇 |
预防医学 | 41篇 |
眼科学 | 30篇 |
药学 | 18篇 |
1篇 | |
肿瘤学 | 24篇 |
出版年
2022年 | 4篇 |
2021年 | 10篇 |
2020年 | 8篇 |
2019年 | 8篇 |
2018年 | 9篇 |
2017年 | 6篇 |
2016年 | 4篇 |
2015年 | 24篇 |
2014年 | 25篇 |
2013年 | 25篇 |
2012年 | 25篇 |
2011年 | 23篇 |
2010年 | 64篇 |
2009年 | 47篇 |
2008年 | 46篇 |
2007年 | 47篇 |
2006年 | 52篇 |
2005年 | 34篇 |
2004年 | 47篇 |
2003年 | 21篇 |
2002年 | 31篇 |
2001年 | 27篇 |
2000年 | 22篇 |
1999年 | 22篇 |
1998年 | 27篇 |
1997年 | 31篇 |
1996年 | 28篇 |
1995年 | 17篇 |
1994年 | 21篇 |
1993年 | 8篇 |
1992年 | 10篇 |
1991年 | 3篇 |
1989年 | 8篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 8篇 |
1985年 | 9篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1978年 | 8篇 |
1976年 | 4篇 |
1974年 | 3篇 |
1973年 | 11篇 |
1972年 | 3篇 |
1960年 | 4篇 |
1958年 | 3篇 |
1956年 | 5篇 |
排序方式: 共有904条查询结果,搜索用时 15 毫秒
901.
Linkage and physical mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain 总被引:6,自引:2,他引:6
Ross ME; Allen KM; Srivastava AK; Featherstone T; Gleeson JG; Hirsch B; Harding BN; Andermann E; Abdullah R; Berg M; Czapansky-Bielman D; Flanders DJ; Guerrini R; Motte J; Mira AP; Scheffer I; Berkovic S; Scaravilli F; King RA; Ledbetter DH; Schlessinger D; Dobyns WB; Walsh CA 《Human molecular genetics》1997,6(4):555-562
While disorders of neuronal migration are associated with as much as 25% of
recurrent childhood seizures, few of the genes required to establish
neuronal position in cerebral cortex are known. Subcortical band
heterotopia (SBH) and lissencephaly (LIS), two distinct neuronal migration
disorders producing epilepsy and variable cognitive impairment, can be
inherited alone or together in a single pedigree. Here we report a new
genetic locus, XLIS, mapped by linkage analysis of five families and
physical mapping of a balanced X;2 translocation in a girl with LIS.
Linkage places the critical region in Xq21-q24, containing the breakpoint
that maps to Xq22.3-q23 by high-resolution chromosome analysis. Markers
used for somatic cell hybrid and fluorescence in situ hybridization
analyses place the XLIS region within a 1 cM interval. These data suggest
that SBH and X-linked lissencephaly are caused by mutation of a single
gene, XLIS, that the milder SBH phenotype in females results from random
X-inactivation (Lyonization), and that cloning of genes from the breakpoint
region on X will yield XLIS.
相似文献
902.
Coexistence of MACC1 and NM23‐H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early‐stage colon cancer 下载免费PDF全文
Ersin Ozturk Secil AK Aksoy Nesrin Ugras Berrin Tunca Serkan Ceylan Gulcin Tezcan Tuncay Yilmazlar Omer Yerci Unal Egeli Gulsah Cecener 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2018,126(2):99-108
The tumor‐node‐metastasis (TNM) classification, the presence of a mucinous component, and signet ring cells are well‐known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early‐stage colon cancer (eCC). Nevertheless, recurrence can unexpectedly occur in some eCC cases after surgical resection. The aims of the present study were to evaluate the relation of dysregulated MACC1, c‐MET, and NM23‐H1 expression with the histopathological features of tumors in recurrence formation in eCC cases. A total of 100 sporadic eCC patients without poor prognosis factors were evaluated in this study. The relationship between the altered expression of MACC1, c‐MET, and NM23‐H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed. The primary outcomes, including 5‐year overall survival (OS) and disease‐free survival (DFS), were also measured. Compared with nonrecurrent patients, the expression level of MACC1 was 8.27‐fold higher, and NM23‐H1 was 11.36‐fold lower in patients with recurrence during the 5‐year follow‐up (p = 0.0345 and p = 0.0301, respectively). In addition, the coexistence of high MACC1 and low NM23‐H1 expression and tumor budding was associated with short OS (p < 0.001). We suggest that the combination of reduced NM23‐H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy. 相似文献
903.
Elif KELE GÜLNERMAN Yamur AM Bülent ELBASAN ebnem SOYSAL Zühre KAYA dil YENCESU Ülker KOAK 《Turkish Journal of Medical Sciences》2021,51(5):2510
Background/aim There are no extensive studies on the QL in children who completed acute lymphoblastic leukemia (ALL) treatment and currently living without any disease in Turkey. Our study aimed to analyze both the QL and the effects of physical, neurocognitive capacities on QL in childhood ALL survivors aged 7–12 years at the time of recruitment.Materials and methodsPedsQL cancer module 3.0 child and proxy report, for ages 5–7 and 8–12 years, WeeFIM scale, BOTMP Short Form, RPM, reading, writing, and mathematics assessment tools, sociodemographic information form were carried out to the children and their family.Results There was no effect of the months since the completion of therapy on pain, anxiety, cognitive problems, perceived physical appearance, and the total QL scores of children and proxy reports (p > 0.05).Children’s physical capacities were significantly worse than healthy controls and have not reached the level of healthy children even after a long time since completion of ALL therapy. There was a significant association between physical capacity and daily independent living status (p < 0.001). Reading, writing, and mathematical skills were significantly associated with the mean time off-treatment (p < 0.001), and the total score of RPM and PedsQL of those with mathematical difficulties were significantly lower than those without any difficulty (p < 0.05).ConclusionThe months after the treatment (off-treatment time) have not affected total and subunit QL scores. As motor skills difficulties will lead to low academic achievement, early recognition direct the parents for immediate intervention. lead to low academic achievement, early recognition could direct the parents for immediate intervention. Planning psychosocial support programs for physical activity and age-appropriate development of patients from the initiation of treatment will increase the QL in childhood ALL with a survival rate of 80% or more. 相似文献
904.
Demet YALIN KEHRBAR Metin
ZGEN Servet YOLBA Ahmet YILDIRIM Nee BAAK TÜRKMEN Ebru
NALAN ETEM Osman FT brahim Hanifi
ZERCAN Süleyman Serdar KOCA 《Turkish Journal of Medical Sciences》2021,51(4):2142
Background/aimThe purpose of this study was to investigate the antiarthritic potentials of the inhibition of Src kinase in vivo and in vitro settings. Materials and methodsArthritis was induced by intradermal injection of chicken type II collagen combined with incomplete Freund’s adjuvant (collagen induced arthritis [CIA] model) in Wistar albino rats. One day after the onset of arthritis, dasatinib, a potent Src kinase inhibitor, (5 mg/kg/day) was given via oral gavage. Tissue Src, Fyn, MAPK and STAT mRNA expressions were determined by real-time polymerase chain reaction. On the other hand, fibroblast like synoviocytes (FLSs) were harvested patients with rheumatoid arthritis (RA) undergoing surgical knee joint replacement. FLSs were stimulated with cytokines and dasatinib was added in different concentrations. MMP –1, –3, and –13 levels in FLSs culture were determined by ELISA.ResultsThe tissue mRNA expressions of Src, Fyn, MAPK and STATs were increased in the arthritis CIA group compared to the control group. Their mRNA expressions in the CIA + dasatinib group were decreased and similar in the control group. In in vitro setting, MMP –1, –3, and –13 expressions from FLSs induced by IL-1β and TNF-α were increased, while dasatinib suppressed their productions from FLSs.ConclusionThe present study shows that the inhibition of Src kinase has antiarthritic potentials in both in vivo and in vitro settings. Src kinase inhibition may be candidate to further research in human RA. 相似文献